• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

1
1
3
5

PUBLISHED

0
2
2
5

PRODUCT TYPE

4
1

Search "Herpes zoster infections Therapy Area Pipeline Report" returned 5 results.

PRODUCT TITLE
Antiviral Therapeutics - Technologies, Markets and Companies Antiviral Therapeutics - Technologies, Markets and Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

December 2014
FROM
Peripheral Neuropathy and Neuropathic Pain 2008 Peripheral Neuropathy and Neuropathic Pain 2008 - Product Thumbnail Image

Peripheral Neuropathy and Neuropathic Pain 2008

This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally PN and NP are causally linked to a number of diseases, however diabetes,...

June 2009
FROM

Global Herpes Market 2014-2018

About Herpes Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area...

December 2014
FROM
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ million by the following Therapeutic Categories: - Glaucoma - Anti-allergy - Anti-infective - Dry Eye - Anti-inflammation...

October 2010
FROM
Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review - Product Thumbnail Image

Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review

Inhibitex, Inc. (Inhibitex) is a development stage biopharmaceutical company engaged in the research and development of innovative products for the treatment of serious infectious diseases. The pipeline...

July 2010
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.